2009 Glycobiology Gordon Research Conference

2009年糖生物学戈登研究会议

基本信息

  • 批准号:
    8039882
  • 负责人:
  • 金额:
    $ 1.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-01-05 至 2011-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a multi-year application for partial support of the biennial Gordon Research Conference on Glycobiology to be held in January 2009 and 2011 at the Ventura Beach Marriott in Ventura, CA. The previous conference was held March 2007 in Ventura, and was fully subscribed. The Glycobiology Gordon Conference is one of the most prestigious forums for the presentation of the latest and most significant research in the area of Glycobiology. The 2009 and 2011 conferences will continue a tradition of emphasis on the structure, function, and biology of macromolecular glycoconjugates of all types. Plans for the 2009 conference are described briefly below and serve as a template for the 2011 meeting. Eleven oral sessions are scheduled for mornings and evenings. The lecture sessions will cover the following topics: Structural Glycobiology (enzymes & Proteins), Mechanisms of Glycosylation, Nerve and Muscle Glycobiology, Structural Glycobiology (glycans & glycomics), Immune Cell Glycobiology, Vascular Glycobiology, Developmental Glycobiology, Cancer & Cell Regulation, Metabolic Regulation, Microbial Glycobiology. Poster sessions will be held each of the four full days in the late afternoon, and will continue informally after the evening sessions. Several factors contribute to the unique success of this conference in the Glycobiology community: a) a 5-minute window of discussion is enforced at the end of each oral presentation (including short talks), b) the conference is held in a cloistered setting where all participants dine and socialize together outside of the sessions, c) afternoon social activities are planned to promote networking, and d) the poster displays are accessible throughout the day and provide the backdrop for refreshments after the evening sessions, which ensures maximal exposure. Speakers and participants will be selected to reflect the international excellence in glycobiology with appropriate balance ensuring representation of young scientists, women, and minorities. In addition to the approximately 31 invited talks, 26 short oral presentations will be selected from outstanding poster abstracts to bring forth the latest developments in the field, and eight Conference Awards (conference fee deferrals) will be available for outstanding abstracts submitted by graduate students, post-docs, and very junior faculty. The breadth of topics and the diversity of techniques employed in this highly multidisciplinary field will attract a diverse group of scientists with a common interest in glycoconjugates and their functions. All applicants will be encouraged to present a poster. The size of the conference has been increased this year to 150 participants. Proper facilities are available to accommodate handicapped individuals who will also be considered equally in the selection of attendees and speakers. The meeting will bring together the leading and developing scientists in the field to present and evaluate the latest and hottest research in the area, and is designed to stimulate the widening application of emerging technologies and concepts in glycobiology to the frontiers of all areas of biomedical research. PUBLIC HEALTH RELEVANCE: Glycosylation of proteins and lipids contributes in many essential ways to the normal function and health of all the tissues and organs in both development and physiology. The field of `Glycobiology' has experienced a recent upsurge on account of new technologies and its success in contributing a mechanistic understanding to a wide range of inherited, acquired and infectious diseases in humans. Collectively, glycan-dependent diseases are united by a common logic of biosynthesis, analytical methodologies and interpretation of phenotypes and disease symptoms, and the Glycobiology Gordon Conference offers a unique forum to bring together investigators from diverse disciplines to intensively explore these issues.
描述(由申请人提供):这是一个多年的申请,部分支持两年一度的戈登糖生物学研究会议将于2009年1月和2011年在文图拉海滩万豪酒店在文图拉,加利福尼亚州举行。上一次会议于2007年3月在文图拉举行,并获得全额订阅。糖生物学戈登会议是介绍糖生物学领域最新和最重要研究的最负盛名的论坛之一。2009年和2011年的会议将继续强调所有类型的大分子糖缀合物的结构,功能和生物学的传统。下文简要介绍了2009年会议的计划,作为2011年会议的模板。上午和晚上安排了11次口头会议。讲座将涵盖以下主题:结构糖生物学(酶和蛋白质),糖基化机制,神经和肌肉糖生物学,结构糖生物学(聚糖和糖组学),免疫细胞糖生物学,血管糖生物学,发育糖生物学,癌症和细胞调节,代谢调节,微生物糖生物学。海报会议将在下午晚些时候举行,并将在晚上会议后继续非正式。有几个因素促成了这次会议在糖生物学界的独特成功:a)每次口头报告结束时,都有5分钟的讨论时间(包括简短的会谈),B)会议在一个封闭的环境中举行,所有与会者在会议之外一起用餐和社交,c)下午的社交活动计划,以促进网络,以及d)海报展示全天都可以参观,并为晚上会议后的茶点提供背景,以确保最大程度的曝光。演讲者和参与者的选择将反映糖生物学的国际卓越性,并确保青年科学家,妇女和少数民族的代表性。除了约31邀请会谈,26个简短的口头报告将从优秀的海报摘要中选出,带来了该领域的最新发展,和八个会议奖(会议费延期)将可用于研究生,博士后和非常初级的教师提交的优秀摘要。在这个高度多学科的领域中采用的主题的广度和技术的多样性将吸引不同的科学家群体,他们对糖缀合物及其功能具有共同的兴趣。所有申请人将被鼓励提交海报。今年的会议规模扩大到150人。提供适当的设施,以容纳残疾人谁也将被平等地考虑在选择与会者和发言者。该会议将汇集该领域领先和发展中的科学家,介绍和评估该领域最新和最热门的研究,旨在促进糖生物学新兴技术和概念在所有领域的广泛应用生物医学研究。 公共卫生关系:蛋白质和脂质的糖基化以许多重要方式在发育和生理学中对所有组织和器官的正常功能和健康做出贡献。“糖生物学”领域最近经历了一个高潮,这是由于新技术及其在促进对人类广泛的遗传性、获得性和传染性疾病的机理理解方面的成功。总的来说,聚糖依赖性疾病由生物合成的共同逻辑,分析方法以及表型和疾病症状的解释结合在一起,糖生物学戈登会议提供了一个独特的论坛,将来自不同学科的研究人员聚集在一起,深入探讨这些问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTOPHER M. WEST其他文献

CHRISTOPHER M. WEST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTOPHER M. WEST', 18)}}的其他基金

Transfer of 5R01GM037539 - 22 CYTOSOLIC PROLINE HYDROXYLATION AND GLYCOSYLATION
5R01GM037539 - 22 胞质脯氨酸羟基化和糖基化的转移
  • 批准号:
    9071719
  • 财政年份:
    2015
  • 资助金额:
    $ 1.1万
  • 项目类别:
Role of mucin-type O-glycosylation in Trypanosoma cruzi biology
粘蛋白型 O-糖基化在克氏锥虫生物学中的作用
  • 批准号:
    7944915
  • 财政年份:
    2010
  • 资助金额:
    $ 1.1万
  • 项目类别:
Role of mucin-type O-glycosylation in Trypanosoma cruzi biology
粘蛋白型 O-糖基化在克氏锥虫生物学中的作用
  • 批准号:
    8284346
  • 财政年份:
    2010
  • 资助金额:
    $ 1.1万
  • 项目类别:
Role of mucin-type O-glycosylation in Trypanosoma cruzi biology
粘蛋白型 O-糖基化在克氏锥虫生物学中的作用
  • 批准号:
    8085753
  • 财政年份:
    2010
  • 资助金额:
    $ 1.1万
  • 项目类别:
Glycoregulation of Skp1 in the cytoplasm and nucleus
Skp1 在细胞质和细胞核中的糖调节
  • 批准号:
    8197789
  • 财政年份:
    2009
  • 资助金额:
    $ 1.1万
  • 项目类别:
2009 Glycobiology Gordon Research Conference
2009年糖生物学戈登研究会议
  • 批准号:
    7754893
  • 财政年份:
    2009
  • 资助金额:
    $ 1.1万
  • 项目类别:
Glycoregulation of Skp1 in the cytoplasm and nucleus
Skp1 在细胞质和细胞核中的糖调节
  • 批准号:
    7744704
  • 财政年份:
    2009
  • 资助金额:
    $ 1.1万
  • 项目类别:
2009 Glycobiology Gordon Research Conference
2009年糖生物学戈登研究会议
  • 批准号:
    7612409
  • 财政年份:
    2009
  • 资助金额:
    $ 1.1万
  • 项目类别:
Glycoregulation of Skp1 in the cytoplasm and nucleus
Skp1 在细胞质和细胞核中的糖调节
  • 批准号:
    7997231
  • 财政年份:
    2009
  • 资助金额:
    $ 1.1万
  • 项目类别:
Glycoregulation of Skp1 in the cytoplasm and nucleus
Skp1 在细胞质和细胞核中的糖调节
  • 批准号:
    8065710
  • 财政年份:
    2009
  • 资助金额:
    $ 1.1万
  • 项目类别:

相似海外基金

Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10590611
  • 财政年份:
    2022
  • 资助金额:
    $ 1.1万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
  • 批准号:
    10706006
  • 财政年份:
    2022
  • 资助金额:
    $ 1.1万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10368975
  • 财政年份:
    2021
  • 资助金额:
    $ 1.1万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
  • 批准号:
    10365254
  • 财政年份:
    2021
  • 资助金额:
    $ 1.1万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10202896
  • 财政年份:
    2021
  • 资助金额:
    $ 1.1万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
  • 批准号:
    10531570
  • 财政年份:
    2021
  • 资助金额:
    $ 1.1万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10541847
  • 财政年份:
    2019
  • 资助金额:
    $ 1.1万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10319573
  • 财政年份:
    2019
  • 资助金额:
    $ 1.1万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10062790
  • 财政年份:
    2019
  • 资助金额:
    $ 1.1万
  • 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
  • 批准号:
    DE170100628
  • 财政年份:
    2017
  • 资助金额:
    $ 1.1万
  • 项目类别:
    Discovery Early Career Researcher Award
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了